Laparoscopic colorectal resection: initial experience in a specialist unit.
The adoption of the laparoscopic approach to colorectal resection has been slow amongst colorectal surgeons principally due to concerns regarding oncological safety. Recent randomized controlled trials have confirmed both the safe and some advantage of this procedure have been performing laparoscopic assisted colorectal resection since 2002 and have now performed over 100 cases on non consecutive and selected patients. We have reviewed our experience with the introduction of this technique. 61 patients were operated on for cancer and 39 for benign disease mainly Crohn's and diverticular disease. Operative time was a median of 128 minutes over the course of study. Conversion rate was 5%. Pathological analysis of the resected specimens in the cancer cases revealed adequate lymph node harvest and margins. No patient had a positive margin and no port site metastasis have been seen. Duration of ileus and length of stay were a median of 0 and 6 days. Post operative morbidity and mortality were comparable to open colorectal surgery with the exception of port site herniation which occurred in 4% of patients. This study suggests that a laparoscopic approach to colorectal resection can be successfully introduced in an Irish hospital setting. The challenge facing Irish surgery is to disseminate this technique in a controlled and safe manner for Irish patients.
Mehigan
B
B
Center for Colorectal Diseases, St. Vincents University Hospital, Elm Park, Dublin 4. bmehigan@rcsi.ie
White
A
A
Winter
D C
DC
Sheehan
K M
KM
Hyland
J M
JM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003082:Colectomy / Q000401:mortality / Q000706:statistics & numerical data; D015179:Colorectal Neoplasms / Q000601:surgery*; D016208:Databases, Factual; D005260:Female; D006757:Hospital Units; D006784:Hospitals, Teaching; D006801:Humans; D007494:Ireland; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D015996:Survival Rate